Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Nov;87(22):8869–8873. doi: 10.1073/pnas.87.22.8869

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

M S Bajaj 1, M N Kuppuswamy 1, H Saito 1, S G Spitzer 1, S P Bajaj 1
PMCID: PMC55061  PMID: 2247459

Abstract

Human plasma contains a factor Xa-dependent inhibitor of tissue factor/factor VIIa complex termed lipoprotein-associated coagulation inhibitor (LACI). The present study examines the site(s) of LACI synthesis. In this study, cultured hepatocytes isolated from normal human liver were found to be essentially negative in LACI mRNA as revealed by Northern blot analysis using a full-length LACI cDNA as probe. The conditioned media from these cultures were also essentially negative for LACI activity. Similarly, poly(A)+ RNA obtained from normal human liver did not contain detectable LACI mRNA. In contrast, cultured human umbilical vein endothelial cells and human lung tissue (rich in endothelium) both contained abundant amounts of LACI mRNA. Moreover, erythrocyte lysates and culture media from normal monocytes, lymphocytes, or neutrophils did not contain measurable LACI activity; these cells were also negative for LACI mRNA. Platelets, however, contained LACI activity. The likely source of platelet LACI is the megakaryocyte cell since a megakaryocyte cell line (MEG-01) was found to contain LACI mRNA and to secrete small amounts of LACI activity. Additionally, human vascular smooth muscle cells and lung fibroblasts were also found to synthesize only small amounts of LACI. From these observations, we conclude that normal liver does not synthesize LACI and that endothelium is the principal source of plasma LACI. The undegraded LACI synthesized by endothelial cells had a molecular weight of approximately 41,000.

Full text

PDF
8869

Images in this article

8871Image
on p.8871
8871Image
on p.8871
8872Image
on p.8872

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abildgaard U., Sandset P. M., Andersson T. R., Odegaard O. R., Rosen S. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material. Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(3):274–277. [PubMed] [Google Scholar]
  2. Aden D. P., Fogel A., Plotkin S., Damjanov I., Knowles B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 1979 Dec 6;282(5739):615–616. doi: 10.1038/282615a0. [DOI] [PubMed] [Google Scholar]
  3. Bajaj M. S., Rana S. V., Wysolmerski R. B., Bajaj S. P. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease. J Clin Invest. 1987 Jun;79(6):1874–1878. doi: 10.1172/JCI113030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Broze G. J., Jr, Miletich J. P. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci U S A. 1987 Apr;84(7):1886–1890. doi: 10.1073/pnas.84.7.1886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broze G. J., Jr, Warren L. A., Novotny W. F., Higuchi D. A., Girard J. J., Miletich J. P. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988 Feb;71(2):335–343. [PubMed] [Google Scholar]
  6. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Decad G. M., Hsieh D. P., Byard J. L. Maintenance of cytochrome P-450 and metabolism of aflatoxin B1 in primary hepatocyte cultures. Biochem Biophys Res Commun. 1977 Sep 9;78(1):279–287. doi: 10.1016/0006-291x(77)91251-7. [DOI] [PubMed] [Google Scholar]
  9. Edwards A. M., Glistak M. L., Lucas C. M., Wilson P. A. 7-Ethoxycoumarin deethylase activity as a convenient measure of liver drug metabolizing enzymes: regulation in cultured rat hepatocytes. Biochem Pharmacol. 1984 May 1;33(9):1537–1546. doi: 10.1016/0006-2952(84)90425-8. [DOI] [PubMed] [Google Scholar]
  10. Girard T. J., Warren L. A., Novotny W. F., Bejcek B. E., Miletich J. P., Broze G. J., Jr Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thromb Res. 1989 Jul 1;55(1):37–50. doi: 10.1016/0049-3848(89)90454-4. [DOI] [PubMed] [Google Scholar]
  11. Girard T. J., Warren L. A., Novotny W. F., Likert K. M., Brown S. G., Miletich J. P., Broze G. J., Jr Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 1989 Apr 6;338(6215):518–520. doi: 10.1038/338518a0. [DOI] [PubMed] [Google Scholar]
  12. Graham M. F., Diegelmann R. F., Elson C. O., Bitar K. N., Ehrlich H. P. Isolation and culture of human intestinal smooth muscle cells. Proc Soc Exp Biol Med. 1984 Sep;176(4):503–507. doi: 10.3181/00379727-176-4-rc1. [DOI] [PubMed] [Google Scholar]
  13. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kletzien R. F., Pariza M. W., Becker J. E., Potter V. R., Butcher F. R. Induction of amino acid transport in primary cultures of adult rat liver parenchymal cells by insulin. J Biol Chem. 1976 May 25;251(10):3014–3020. [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Loretz L. J., Li A. P., Flye M. W., Wilson A. G. Optimization of cryopreservation procedures for rat and human hepatocytes. Xenobiotica. 1989 May;19(5):489–498. doi: 10.3109/00498258909042288. [DOI] [PubMed] [Google Scholar]
  17. McGarrity S. T., Hyers T. M., Webster R. O. Inhibition of neutrophil functions by platelets and platelet-derived products: description of multiple inhibitory properties. J Leukoc Biol. 1988 Aug;44(2):93–100. doi: 10.1002/jlb.44.2.93. [DOI] [PubMed] [Google Scholar]
  18. Mustard J. F., Perry D. W., Ardlie N. G., Packham M. A. Preparation of suspensions of washed platelets from humans. Br J Haematol. 1972 Feb;22(2):193–204. doi: 10.1111/j.1365-2141.1972.tb08800.x. [DOI] [PubMed] [Google Scholar]
  19. Nemerson Y. Tissue factor and hemostasis. Blood. 1988 Jan;71(1):1–8. [PubMed] [Google Scholar]
  20. Novotny W. F., Girard T. J., Miletich J. P., Broze G. J., Jr Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 1988 Dec;72(6):2020–2025. [PubMed] [Google Scholar]
  21. Novotny W. F., Girard T. J., Miletich J. P., Broze G. J., Jr Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem. 1989 Nov 5;264(31):18832–18837. [PubMed] [Google Scholar]
  22. Ogura M., Morishima Y., Ohno R., Kato Y., Hirabayashi N., Nagura H., Saito H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood. 1985 Dec;66(6):1384–1392. [PubMed] [Google Scholar]
  23. Ogura M., Tanabe N., Nishioka J., Suzuki K., Saito H. Biosynthesis and secretion of functional protein S by a human megakaryoblastic cell line (MEG-01). Blood. 1987 Jul;70(1):301–306. [PubMed] [Google Scholar]
  24. Rana S. V., Reimers H. J., Pathikonda M. S., Bajaj S. P. Expression of tissue factor and factor VIIa/tissue factor inhibitor activity in endotoxin or phorbol ester stimulated U937 monocyte-like cells. Blood. 1988 Jan;71(1):259–262. [PubMed] [Google Scholar]
  25. Rapaport S. I. Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood. 1989 Feb;73(2):359–365. [PubMed] [Google Scholar]
  26. Reese J. A., Byard J. L. Isolation and culture of adult hepatocytes from liver biopsies. In Vitro. 1981 Nov;17(11):935–940. doi: 10.1007/BF02618417. [DOI] [PubMed] [Google Scholar]
  27. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  28. Sanders N. L., Bajaj S. P., Zivelin A., Rapaport S. I. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood. 1985 Jul;66(1):204–212. [PubMed] [Google Scholar]
  29. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Scarpati E. M., Sadler J. E. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem. 1989 Dec 5;264(34):20705–20713. [PubMed] [Google Scholar]
  31. Spitzer S. G., Pendurthi U. R., Kasper C. K., Bajaj S. P. Molecular defect in factor IXBm Lake Elsinore. Substitution of Ala390 by Val in the catalytic domain. J Biol Chem. 1988 Aug 5;263(22):10545–10548. [PubMed] [Google Scholar]
  32. Warn-Cramer B. J., Almus F. E., Rapaport S. I. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells. Thromb Haemost. 1989 Feb 28;61(1):101–105. [PubMed] [Google Scholar]
  33. Warn-Cramer B. J., Rao L. V., Maki S. L., Rapaport S. I. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition. Thromb Haemost. 1988 Dec 22;60(3):453–456. [PubMed] [Google Scholar]
  34. Warr T. A., Rao L. V., Rapaport S. I. Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease. Blood. 1989 Aug 15;74(3):994–998. [PubMed] [Google Scholar]
  35. Wun T. C., Kretzmer K. K., Girard T. J., Miletich J. P., Broze G. J., Jr Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem. 1988 May 5;263(13):6001–6004. [PubMed] [Google Scholar]
  36. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES